OCTAGAM
Biological
Octapharma USA, Inc.
Total Payments
$1.4M
Transactions
1,344
Doctors
589
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $2,677 | 152 | 127 |
| 2018 | $741,470 | 611 | 310 |
| 2017 | $605,925 | 581 | 232 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 381 | 94.6% |
| Consulting Fee | $41,199 | 20 | 3.1% |
| Food and Beverage | $18,333 | 893 | 1.4% |
| Travel and Lodging | $13,478 | 48 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102.70 | 2 | 0.0% |
Payments by Type
Research
$1.3M
381 transactions
General
$73,113
963 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| GAM5-28 | Octapharma USA, Inc. | $765,165 | 2 |
| GAM10-08 | Octapharma USA, Inc. | $511,795 | 7 |
Top Doctors Receiving Payments for OCTAGAM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chicago, IL | $1.2M | 329 |
| , MD | Rheumatology | Waco, TX | $31,943 | 3 |
| , MD | Rheumatology | Farmington, CT | $21,700 | 9 |
| , MD | Dermatology | Palo Alto, CA | $18,125 | 9 |
| , M.D | Rheumatology | Pittsburgh, PA | $17,959 | 4 |
| , MD | Dermatology | Philadelphia, PA | $5,847 | 13 |
| , M.D | Neurology | Fort Wayne, IN | $5,654 | 8 |
| , MD | Neurology | Sarasota, FL | $5,484 | 9 |
| , MD | Neurology | Burlington, VT | $5,456 | 7 |
| , MD | Neurology | Tampa, FL | $5,393 | 10 |
| , MD | Rheumatology | Brighton, MA | $5,344 | 13 |
| , MD | Neurology | Boston, MA | $5,255 | 8 |
| , M.D | Neurology | Minneapolis, MN | $5,150 | 11 |
| , MD | Neurology | Nashville, TN | $5,096 | 8 |
| , MD, MSC | Neurology | New Haven, CT | $5,068 | 5 |
| , M.D | Allergy | New York, NY | $4,948 | 7 |
| , M.D | Neurology | Los Angeles, CA | $4,908 | 8 |
| , M.D | Neurology | Burlington, VT | $4,804 | 2 |
| , MD | Rheumatology | Los Angeles, CA | $975.00 | 1 |
| , M.D | Allergy & Immunology | Chicago, IL | $720.83 | 3 |
| , M.D | Allergy & Immunology | Omaha, NE | $677.83 | 12 |
| , M.D | Pediatrics | Papillion, NE | $662.83 | 6 |
| , M.D | Internal Medicine | Fountain Valley, CA | $352.00 | 8 |
| , M.D | Internal Medicine | Bedford, TX | $352.00 | 8 |
| , M.D | Hematology & Oncology | Fountain Valley, CA | $352.00 | 8 |
Ad
Manufacturing Companies
- Octapharma USA, Inc. $1.3M
- PFIZER INC. $2,444
- HOSPIRA, INC. $232.58
Product Information
- Type Biological
- Total Payments $1.4M
- Total Doctors 589
- Transactions 1,344
About OCTAGAM
OCTAGAM is a biological associated with $1.4M in payments to 589 healthcare providers, recorded across 1,344 transactions in the CMS Open Payments database. The primary manufacturer is Octapharma USA, Inc..
Payment data is available from 2017 to 2019. In 2019, $2,677 was paid across 152 transactions to 127 doctors.
The most common payment nature for OCTAGAM is "Unspecified" ($1.3M, 94.6% of total).
OCTAGAM is associated with 2 research studies, including "GAM5-28" ($765,165).